Cancer Therapies
Cancer Therapies
Targeted Cancer Therapies
Targeted Cancer Therapies
Treatment Resistent Cancers
Treatment Resistant Cancers
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
A Ben Aïssa1, A-C George, F Z El M'Rabet
1Service d'oncologie, HUG, 1211 Genève. assma.benaissa@hcuge.ch
Vascular endothelial growth factor (VEGF) inhibitors are crucial cancer drugs but can cause silent hypertension and proteinuria. Regular monitoring and management are essential for patient safety during antiangiogenic therapy.
Area of Science: